The Gabapentin market size is expected to reach $4.45 billion in 2030 at a CAGR of 8.1%, driven by rising epilepsy prevalence.
Read More
The G Protein-Coupled Receptors (GPCR) Structure-Based Drug Design market size is expected to reach $4.89 billion in 2030 at a CAGR of 13.0%, driven by demand for precision medicine.
Read More
The Functional Supplements market size is expected to reach $104.42 billion in 2030 at a CAGR of 9.4%, driven by growing health and wellness awareness.
Read More
The Functional Dyspepsia Drug market size is expected to reach $12.24 billion in 2030 at a CAGR of 6.2%, driven by rising metabolic disorder prevalence.
Read More
The Fulvestrant Injection market size is expected to reach $1.97 billion in 2030 at a CAGR of 8.0%, driven by rising breast cancer prevalence.
Read More
The Fuchs Endothelial Corneal Dystrophy market size is expected to reach $271.04 billion in 2030 at a CAGR of 7.8%, driven by growing corneal transplant demand.
Read More
The Fracture Management Products market size is expected to reach $12.97 billion in 2030 at a CAGR of 6.0%, driven by rising sports-related injuries.
Read More
The Foot Fungal Spray market size is expected to reach $2.29 billion in 2030 at a CAGR of 8.7%, driven by increasing personal hygiene awareness.
Read More
The Food Pathogen Detection Technology market size is expected to reach $9.37 billion in 2030 at a CAGR of 7.9%, driven by rising food safety concerns.
Read More
The Fondaparinux market size is expected to reach $2.81 billion in 2030 at a CAGR of 7.2%, driven by rising thromboembolic conditions.
Read More